医学
曲折
无容量
队列
肺癌
内科学
免疫疗法
放射科
肿瘤科
癌症
多孔性
工程类
岩土工程
作者
Vamsidhar Velcheti,Mehdi Alilou,Monica Khunger,Rajat Thawani,Anant Madabhushi
标识
DOI:10.1016/j.jtho.2017.06.067
摘要
We sought to evaluate whether computer extracted measurements of vessel tortuosity significantly and differentially change post treatment between NSCLC patients who do and do not respond to immunotherapy. A total of 50 NSCLC patients including pre- and post- treatment CT scans were included in this study. The patients were either responders or non-responders to Nivolumab. Patients who did not receive Nivolumab after 2 cycles due to lack of response or progression as per RECIST were classified as non-responders. A total of 35 tortuosity features of the vessels around the lung nodules were investigated. In the training cohort (N = 25), the features were ranked based on the degree of change between pre- and post- treatment CT. The top 4 features were used for training a Support Vector Machine (SVM) classifier to identify which patients did and did not respond to immunotherapy on a validation cohort of N = 25 patients. The top features identified were the ones associated with the curvature of the vessel branches. The AUC for the SVM classifier was 0.75 for the training and 0.79 for the test set. Changes in specific vessel tortuosity features between baseline and post-treatment CT scans following nivolumab were different between NSCLC patients who did and did not respond.
科研通智能强力驱动
Strongly Powered by AbleSci AI